Dr. Lebwohl reviews the new biologic agents that are being introduced for the treatment of psoriasis. The advantages and disadvantages of each of the agents are discussed.
Dr. Lebwohl is a member of the medical advisory board of the National Psoriasis Foundation and editor of Psoriasis Forum as well as medical editor of The Bulletin of the National Psoriasis Foundation. He is the "Medical Pearl" feature editor as well as assistant editor of The Journal of the American Academy of Dermatology. He has chaired numerous symposia and has written or edited several books including Difficult Diagnoses in Dermatology, Psoriasis, and Atlas of the Skin and Systemic Disease. Dr. Lebwohl has authored or co-authored over 400 publications including articles, chapters and abstracts. He is actively involved in clinical trials of new dermatologic treatments.